• 1
    Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol. 2001; 165: 10671077.
  • 2
    Laurent TC, Fraser JRE. Hyaluronan. FASEB J. 1992; 6: 23972404.
  • 3
    Lokeshwar VB, Block NL. HA-HAase urine test, a sensitive method for detecting bladder cancer and evaluating its grade. Urol Clin North Am. 2000; 27: 5361.
  • 4
    Lokeshwar VB, Soloway MS, Block NL. Secretion of bladder tumor derived hyaluronidase activity by invasive bladder tumor cells. Cancer Lett. 1998; 131: 2127.
  • 5
    Pham HT, Block NL, Lokeshwar VB. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Res. 1997; 57: 778783.
  • 6
    Gmachi M, Sagan S, Ketter S, Kreil G. The human sperm protein PH20 has hyaluronidase activity. FEBS Lett. 1993; 336: 545548.
  • 7
    Csoka AB, Frost GI, Heng HH, et al. The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. Genomics. 1998; 48: 6370.
  • 8
    Lepperdinger G, Strobl B, Kreil G. HYAL2, a human gene expressed in many cells, encode a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem. 1998; 273: 2246622470.
  • 9
    Lokeshwar VB, Young MJ, Goudarzi G, et al. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res. 1999; 59: 44644470.
  • 10
    McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53 and CD44. Am J Surg Pathol. 2001; 25: 10741078.
  • 11
    Burchill SA, Bradbury MF, Smith B, Lewis IJ, Selby P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer. 1994; 57: 671675.
  • 12
    Sobin LH, Wittkind C. UICC TNM classification of malignant tumors (5th edition). New York, NY: Wiley Liss, 1997: 187.
  • 13
    Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual (2nd edition). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989: 4259.
  • 14
    Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976; 72: 248251.
  • 15
    Frost G, Ćoska TB, Wong T, Stern R. Purification, cloning and expression of human plasma hyaluronidase. Biochem Biophys Res Commun. 1997; 236: 1015.
  • 16
    Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995; 71: 287.
  • 17
    Okamoto I, Morisaki T, Sasaki J, et al. Molecular detection of cancer cells by competitive RT-PCR analysis of specific CD44 variant RNAs. J Natl Cancer Inst. 1998; 90: 304315.
  • 18
    Southgate J, Smith B, Burchill SA, et al. Detection of epithelial cancer cells in peripheral blood by RT-PCR. Br J Cancer. 1995; 71: 278281.
  • 19
    Hughes JH, Raab SS, Cohen MB. The cytologic diagnosis of low-grade transitional cell carcinoma. [Review]. Am J Clin Pathol. 2000; 114(Suppl): S59S67.
  • 20
    Eissa S, Kassim S, El-Ahmady O. Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers. Curr Opin Obstet Gynecol. 2003; 15: 395403.
  • 21
    Raab SS, Slagel DD, Jensen CS, et al. Transitional cell carcinoma: cytologic criteria to improve diagnostic accuracy. Mod Pathol. 1996; 9: 225232.
  • 22
    Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest. 1983; 52: 243265.
  • 23
    Osborne M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest. 1983; 48: 372394.
  • 24
    Lane EB, Alexander CM. Use of keratins antibodies in tumor diagnosis. Semin Cancer Biol. 1990; 1: 165179.
  • 25
    Desai S, Lim SD, Jimenez RE, et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urolthelial neoplasia. Mod Pathol. 2000; 12: 13151323.
  • 26
    Klein A, Zemer R, Buchumensky V, Klaoer R, Nissenkorn I. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer. 1998; 82: 349354.
  • 27
    Rotem D, Cassel A, Lindenfeld N, Mecz Y, Resnick M, Stein A. Urinary cytokeratin 20 as a marker for transitional cell carcinoma. Eur Urol. 2000; 5: 601604.
  • 28
    Eissa S, Kenawy G, Swellam M, et al. Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clin Biochem. 2004; 37: 803809.